Rottneros AB (publ) (STO:RROS)
Sweden flag Sweden · Delayed Price · Currency is SEK
2.910
-0.090 (-3.00%)
Aug 1, 2025, 5:29 PM CET

Inozyme Pharma Market Cap

Rottneros AB has a market cap or net worth of 776.97 million as of August 1, 2025. Its market cap has decreased by -56.47% in one year.

Market Cap
776.97M
Enterprise Value
1.33B
Revenue
2.68B
Ranking
n/a
PE Ratio
n/a
Stock Price
$2.91

Market Cap Chart

Since August 11, 1993, Rottneros AB's market cap has increased from 458.32M to 776.97M, an increase of 69.53%. That is a compound annual growth rate of 1.66%.

History

DateMarket Cap% Change
Aug 1, 2025776.97M-43.16%
Dec 30, 20241.37B-26.44%
Dec 29, 20231.86B-0.33%
Dec 30, 20221.86B17.27%
Dec 30, 20211.59B27.85%
Dec 30, 20201.24B-28.51%
Dec 30, 2019 Pro Pro
Dec 28, 2018 Pro Pro
Dec 29, 2017 Pro Pro
Dec 30, 2016 Pro Pro
Dec 30, 2015 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

CompanyMarket Cap
Svenska Cellulosa Aktiebolaget SCA86.30B
Boliden AB85.48B
Holmen AB57.10B
SSAB AB55.16B
HEXPOL AB28.48B
Billerud AB20.70B
Alleima AB17.14B
Gränges AB13.99B
Market Cap Rankings